首页> 中文期刊> 《当代医学》 >疏血通注射液联合脑络舒通汤治疗急性脑梗死的疗效分析

疏血通注射液联合脑络舒通汤治疗急性脑梗死的疗效分析

         

摘要

目的:探讨疏血通注射液联合脑络舒通汤治疗急性脑梗死的临床疗效。方法选取急性脑梗死患者95例,随机分为研究组(n=48)和对照组(n=47)。对照组予以疏血通注射液治疗,研究组予以疏血通注射液联合脑络舒通汤治疗,分析2组治疗效果。结果治疗后研究组各症状症候积分和全血粘度(4.02±0.15)、血浆粘度(1.46±0.14)、红细胞聚集指数水平(2.36±0.47)均优于对照组,差异有统计学意义(P<0.05)。结论疏血通注射液联合脑络舒通汤治疗可显著缓解急性脑梗死的临床症状,优化患者血循环,值得临床推广应用。%Objective To explore Shuxuetong injection combined with spironolactone soup Naoluo treatment of acute cerebral infarction. Methods Data were randomly selected 95 cases of acute cerebral infarction, were randomly divided into study group of 48 patients in the control group of 47 cases. The control group received Shuxuetong injection therapy, the study group be Shuxuetong injection combined with spironolactone Treated Naoluo analyze the effect of the two groups.Results After studying each treatment group symptom symptom scores andηb (4.02 ± 0.15),ηp (1.46 ± 0.14), erythrocyte aggregation index levels (2.36 ± 0.47) than the control group, the difference was statistically significant (P<0.05). Conclusion Shuxuetong injection combined with spironolactone Naoluo decoction can significantly relieve symptoms of acute cerebral infarction, optimize blood circulation in patients with clinical applications.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号